News & Updates

Show Multimedia Only

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

26 Jan 2026 by

Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduces 3-year risks of major adverse cardiac events (MACE) and all-cause mortality in patients with type 2 diabetes (T2D) and coronary ischaemia, irrespective of the completeness of revascularization, researchers from the University of Hong Kong (HKU) have reported.

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

26 Jan 2026

Low-dose spironolactone helps regulate blood pressure in primary aldosteronism

23 Jan 2026

Treatment with spironolactone at low doses helps improve blood pressure control in patients with primary aldosteronism, with the added benefit of reduced adverse effects, as shown in a retrospective study.

Low-dose spironolactone helps regulate blood pressure in primary aldosteronism

23 Jan 2026

Serum FT3 levels inversely linked to DPN in euthyroid patients with T2D

23 Jan 2026

Low free triiodothyronine (FT3) is associated with diabetic peripheral neuropathy (DPN) in euthyroid patients with type 2 diabetes (T2D), according to a study.

Serum FT3 levels inversely linked to DPN in euthyroid patients with T2D

23 Jan 2026

Gestational glucose intolerance may raise obesity risk in childhood

23 Jan 2026

Older children and adolescents with exposure to gestational glucose intolerance (GGI)-1 (abnormal value) and gestational diabetes mellitus (GDM) in utero tend to be at greater risk of obesity than those born to normal glucose tolerance (NGT) pregnancies, reports a study, which also accounted for maternal BMI.

Gestational glucose intolerance may raise obesity risk in childhood

23 Jan 2026

Menopause timing, type not linked to diabetes risk

23 Jan 2026

Neither the timing nor type of menopause appears to influence the risk of diabetes, according to a study.

Menopause timing, type not linked to diabetes risk

23 Jan 2026

Dyslipidemia tied to higher NK cell cytotoxicity in women with recurrent pregnancy loss

22 Jan 2026

Dyslipidemia appears common in many women with recurrent pregnancy loss (RPL), reveals a recent study. Additionally, those with a history of RPL and dyslipidemia tend to be at increased risk of autoimmune and cellular immune abnormalities.

Dyslipidemia tied to higher NK cell cytotoxicity in women with recurrent pregnancy loss

22 Jan 2026

SGLT2i may delay hormone therapy failure in prostate cancer

22 Jan 2026 by

Intention-to-treat (ITT) SGLT2 inhibitor (SGLTi) use was associated with reduced risk of androgen deprivation therapy (ADT) and androgen receptor pathway inhibitor (APRI) failure, according to findings of a population-based study in Hong Kong.

SGLT2i may delay hormone therapy failure in prostate cancer

22 Jan 2026

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

20 Jan 2026

Nonmetastatic breast cancer survivors who are genetically predisposed to having an excess body weight appear to be at increased risk of mortality, as shown in a study.

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

20 Jan 2026

Simvastatin does little to prevent recurrence of pancreatitis

17 Jan 2026

Treatment with simvastatin does not appear to reduce the recurrence of pancreatitis when compared with placebo, according to interim data from a study.

Simvastatin does little to prevent recurrence of pancreatitis

17 Jan 2026

Human milk composition tied to maternal overweight/obesity, low supply

14 Jan 2026

Maternal overweight/obesity (OW) can alter the composition of human milk (HM) and affect infant milk intake, suggests a study.

Human milk composition tied to maternal overweight/obesity, low supply

14 Jan 2026

News & Updates

Showing Endocrinology articles

Showing

Specialty:

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

SGLT2i use improves prognosis in T2D patients with coronary ischaemia

Low-dose spironolactone helps regulate blood pressure in primary aldosteronism

Low-dose spironolactone helps regulate blood pressure in primary aldosteronism

Serum FT3 levels inversely linked to DPN in euthyroid patients with T2D

Serum FT3 levels inversely linked to DPN in euthyroid patients with T2D

Gestational glucose intolerance may raise obesity risk in childhood

Gestational glucose intolerance may raise obesity risk in childhood

Menopause timing, type not linked to diabetes risk

Menopause timing, type not linked to diabetes risk

Dyslipidemia tied to higher NK cell cytotoxicity in women with recurrent pregnancy loss

Dyslipidemia tied to higher NK cell cytotoxicity in women with recurrent pregnancy loss

SGLT2i may delay hormone therapy failure in prostate cancer

SGLT2i may delay hormone therapy failure in prostate cancer

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors

Simvastatin does little to prevent recurrence of pancreatitis

Simvastatin does little to prevent recurrence of pancreatitis

Human milk composition tied to maternal overweight/obesity, low supply

Human milk composition tied to maternal overweight/obesity, low supply